Skip to content

A pilot study of patients in cardiac arrest utilising a heart-lung bypass machine prior to transport to hospital to improve survival rates.

CPR, pre-Hospital ECMO and Early Reperfusion (CHEER 3 Trial) for patients in refractory cardiac arrest to improve survival to hospital discharge.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000303145
Acronym
CHEER 3
Enrollment
34
Registered
2019-02-27
Start date
2021-04-28
Completion date
2026-01-31
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The CHEER 3 Trial is a treatment strategy aimed at providing hope for patients who are otherwise very likely to die. In patients who suffer cardiac arrest, a range of interventions such as CPR, defibrillation and injection of drugs are provided at the scene by paramedics to attempt to restart the heart. If paramedics are unsuccessful, there is very little hope of recovery and the patient is usually declared deceased at scene. Transport to hospital with CPR may be attempted but previous research indicates this is usually unsuccessful due to the time taken to arrive at hospital for further treatments. This trial will evaluate an alternative approach involving doctors from The Alfred Hospital being transported to the scene and placing the patient on a heart-lung machine called ECMO. Once stabilised on ECMO, the patient will then be taken to the Alfred Hospital for further investigations and treatment.

Interventions

All patients enrolled in the trial will undergo CPR at the scene prior to and after enrolment into the trial until ECMO is functioning. All enrolled patients will have ECMO attempted and if successful, these patients will then be transported to hospital for further management including transfer to the catheterisation lab if appropriate. Both pre-hospital ambulance care records and Alfred Hospital records will be reviewed by investigators for compliance, to identify any problems and for data coll

All patients enrolled in the trial will undergo CPR at the scene prior to and after enrolment into the trial until ECMO is functioning. All enrolled patients will have ECMO attempted and if successful, these patients will then be transported to hospital for further management including transfer to the catheterisation lab if appropriate. Both pre-hospital ambulance care records and Alfred Hospital records will be reviewed by investigators for compliance, to identify any problems and for data collection. Treatment: Device - Extracorporeal Membrane Oxygenation (ECMO) Insertion of peripheral veno-arterial ECMO at scene of cardiac arrest by ECMO team including two Intensive Care Consultants Treatment: Cardiopulmonary Resuscitation (CPR) CPR will be given to the patient until ECMO has been implemented. Treatment: Early Reperfusion Once the patient has been transported to hospital, they will be taken directly to the Catheterisation Lab if appropriate.

Sponsors

Ambulance Victoria
Lead SponsorGovernment body

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Age 18 to 70 years Witnessed cardiac arrest (bystander or paramedic) Time from arrest to commence chest compressions of less than 5 minutes Duration of cardiac arrest between 20 and 45 minutes Initial cardiac rhythm of Ventricular Fibrillation/pulseless Ventricular Tachycardia/Pulseless Electrical Activity In cardiac arrest on arrival of ECMO team

Exclusion criteria

Traumatic arrest including hanging Known to have significant life-limiting co-morbidities (eg COPD/cirrhosis/dementia) or terminal illness

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026